6 Months of Bedaquiline(BDQ), Delamanid(DLM), Linezolid(LZD) and Levofloxacin(LFX) in RR-TB Patients in Hubei Province

NCT07198685 · clinicaltrials.gov ↗

NA

Phase

NOT_YET_RECRUITING

Status

52

Enrollment

OTHER

Sponsor class

Conditions

Treat to Target
Treatment Duration

Interventions

DRUG: bedaquiline
DRUG: Delamanid (DLM)
DRUG: Linezolid (LZD)
DRUG: Levofloxacin
DRUG: Cycloserine
DRUG: Clofazimine

Sponsor

Wuhan Pulmonary Hospital